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Patients with anorexia nervosa (AN) exhibit volume reduction in cerebral gray matter (GM), 23 
and several studies report reduced hippocampus volume. The hippocampal subfields (HS) are 24 
functionally and structurally distinct, and appear to respond differently to neuropathology. 25 
The aim of this study was to investigate HS volumes in adolescent females with restrictive 26 
AN compared to a healthy age-matched control group (HC). The FreeSurfer v6.0 package was 27 
used to extract brain volumes, and segment HS in 58 female adolescents (AN=30, HC=28). 28 
We investigated group differences in GM, white matter (WM), whole hippocampus and 12 29 
HS volumes. AN patients had significantly lower total GM and total hippocampal volume. No 30 
group difference was found in WM. Volume reduction was found in 11 of the 12 HS, and 31 
most results remained significant when adjusting for global brain volume reduction. 32 
Investigations of clinical covariates revealed statistically significant relationships between the 33 
whole hippocampus, several HS and scores on depression and anxiety scales in AN. Results 34 
from this study show that young AN patients exhibit reduced volume in most subfields of the 35 
hippocampus, and that this reduction may be more extensive than the observed global cerebral 36 
volume loss. 37 
 38 
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1. Introduction 41 
Anorexia nervosa (AN) is a severe mental health disorder characterized by a disturbance in 42 
body image perception and a restriction of nutrient intake resulting in abnormally low body 43 
weight (American Psychiatric Association, 2013). Patients with AN have significantly 44 
elevated mortality rates compared to other mental health disorders (Arcelus et al., 2011) and 45 
the majority have their illness debut during adolescence. Brain imaging studies consistently 46 
find that global gray matter (GM) volume is reduced in patients with AN, although there are 47 
some discrepancies regarding the degree of atrophy and affected areas (Gaudio et al., 2011; 48 
King et al., 2015; Seitz et al., 2016). A recent meta-analysis concluded that GM reduction is 49 
significantly greater in adolescent patients with AN compared to adults (Seitz et al., 2016). 50 
Findings regarding white matter (WM) are inconsistent, but recent studies suggest that WM 51 
volume and integrity are better preserved in young patients with AN compared to adults 52 
(Pfuhl et al., 2016; Seitz et al., 2016). Longitudinal studies indicate that total brain volume 53 
mostly normalizes as patients recover (Bernardoni et al., 2016; Mainz et al., 2012), but it is 54 
yet unclear whether regeneration is total and if it applies to all cerebral regions. 55 
Volume reduction of the hippocampus formation has been reported in several studies 56 
in both adults (Burkert et al., 2015; Chui et al., 2008; Connan et al., 2006; King et al., 2015; 57 
Mainz et al., 2012). The formation of the hippocampus is well known for its involvement in 58 
learning and memory, but also plays an important role in emotional regulation (Fanselow and 59 
Dong, 2010). Hippocampal atrophy is evident in other severe mental health disorders, such as 60 
major depression (Treadway et al., 2015), schizophrenia (Wright et al., 2000), bipolar 61 
disorder (Haukvik et al., 2015), post-traumatic stress disorder (PTSD) (Hayes et al., 2017) and 62 
borderline personality disorder (Driessen et al., 2000) and a common underlying mechanism 63 
driven by stress and elevated glucocorticoid levels has been proposed (Sapolsky, 2000). 64 
Patients with AN often experience comorbid symptoms of depression and anxiety (Kaye et 65 
al., 2004; O’Brien and Vincent, 2003). The link between hippocampal volume reduction and 66 
comorbid symptoms has not been extensively investigated. One study found no relationship 67 
between depression and coping and hippocampus volume in adult AN (Burkert et al., 2015).  68 
The hippocampus is a heterogeneous structure with multiple cell layers and several 69 
distinct “hippocampal subfields” (HS) that are structurally and functionally different from one 70 
another (Duncan et al., 2012; Leutgeb et al., 2007; Zeineh et al., 2000; Zhu et al., 2017). 71 
Advanced new methods for segmentation of the hippocampus enable examination of the HS 72 
separately. The FreeSurfer v6.0 hippocampal subfields atlas was built from ultra-high 73 




can model 13 segments, and has been shown to perform well in neurodegenerative disease 75 
populations (Iglesias et al., 2015).  76 
A number of neuroimaging studies have investigated HS separately in disease 77 
populations and found that neuropathology can affect these regions differently. Among 78 
patients with severe mental health disorders, the most frequently reported findings are volume 79 
reduction in the CA structures, the subiculum and dentate gyri (Haukvik et al., 2015; Hayes et 80 
al., 2017; Ho et al., 2017; Ota et al., 2017; Treadway et al., 2015). A recent study found that 81 
Cornu Ammonis 1 (CA1) volume was reduced in early stages of schizophrenia, but that 82 
atrophy spread to other subfields as the illness progressed (Ho et al., 2017), indicating that 83 
duration of illness may be an important factor to consider when studying volume reduction in 84 
the hippocampus in mental health disorders.  85 
To our knowledge, only one previous study has investigated HS in AN patients 86 
(Burkert et al., 2015). Adult AN patients who had been ill for several years were found to 87 
have a significant reduction in the fimbria – a white matter bundle projecting along the 88 
anterior-posterior axis of the hippocampus (Burkert et al., 2015), and an increase in the size of 89 
the hippocampal fissure – the “ventricle” of the hippocampus. Recent studies suggest that 90 
variability in duration of AN, which typically debuts in adolescents, may lead to different 91 
findings in neuroimaging studies of adults and adolescent (Pfuhl et al., 2016; Seitz et al., 92 
2016). It is therefore of interest to investigate the hippocampus and HS volumes in the early 93 
stages of AN.  94 
The studies that have reported hippocampal atrophy in AN (Burkert et al., 2015; 95 
Connan et al., 2006; Giordano et al., 2001; Mainz et al., 2012) vary in their methods of 96 
correction for individual differences in brain volume. None of the reported studies have aimed 97 
to investigate the selective effect of AN on the hippocampus by adjusting for the observed 98 
global brain volume reduction. It remains unclear whether the hippocampus is particularly 99 
affected in AN, or if the volume reduction in the hippocampus is a consequence of the 100 
observed global volume reduction. Furthermore, methods of segmentation vary and results 101 
from the manual delineation of HS can be particularly difficult to replicate (Van Leemput et 102 
al., 2009). Further investigation is needed to reveal the relationship between AN and the 103 
hippocampus and its subfields.  104 
The aim of the current study was to examine HS in young patients in an early stage of 105 
AN. We investigated 12 subfields segmented by the hippocampal subfields segmentation tool 106 
in the FreeSurfer software package (Iglesias et al., 2015) – a fully automated algorithm. We 107 




the whole hippocampus compared to healthy age-matched controls. We expected to find a 109 
selective HS volume reduction and an increased fissure, similar to what has been found 110 
previously in adult AN patients (Burkert et al., 2015). Furthermore, we investigated if HS 111 
volumes were significantly smaller in AN patients when adjusting for total brain volume - 112 
which we expected to be reduced in AN. As HS volume reduction is also found in mental 113 
health disorders that often occur as comorbid conditions in AN patients, we wished to further 114 
explore the association between HS volume, AN symptoms and symptoms of anxiety and 115 
depression. We expected to find a negative relative relationship between HS volumes and 116 
symptoms of depression and anxiety. 117 




2. Methods 119 
2.1. Study design and sample  120 
Inpatients with AN were recruited from the Regional Center for Eating Disorders at the 121 
University Hospital of North Norway (RSS) and Oslo University Hospital (RASP). In total, 122 
33 female patients with AN (Age: M=15.8, SD=1.7) and 30 female healthy age-matched 123 
controls (Age: M=16.2, SD=1.9) were recruited for the study (10 patients and 10 controls 124 
were tested and scanned at RASP). Healthy controls (HC) were recruited from local high 125 
schools. Neuropsychological testing and scanning was conducted less than two weeks apart. 126 
All participants were scanned in the evening between 3 pm and 8 pm. 127 
Inclusion criteria for AN patients were the DSM-V criteria for restrictive AN (no 128 
history of binge-purge episodes), diagnosis set by a clinical specialist in psychology or 129 
medicine. Age-adjusted, standardized body mass indexvalues (BMI-SDS) were calculated 130 
using Norwegian normative data from the Bergen Growth Study (Júlíusson et al., 2013). A 131 
measure of body mass index increase between admission and scanning (BMI-increase) was 132 
calculated by subtracting body mass index (BMI) at admission from BMI at the day of 133 
scanning. Exclusion criteria for all participants were neurological disorders and organic brain 134 
injury, history of bulimia nervosa, schizophrenia, psychotic episodes and the use of 135 
antipsychotic medication. Additional exclusion criteria for HC were lifetime or current eating 136 
disorders or obesity (BMI > 30).  137 
 138 
2.2. Ethics 139 
The Norwegian Committee for Medical and Health Research Ethics (REC), North region 140 
approved the study, under protocol number 302969. Informed, written consent was obtained 141 
from all participants. Parents also gave written consent for participants <16 years of age.  142 
 143 
2.3. Image acquisition 144 
MR scanning was performed with a 3T Siemens Magnetom Skyra Syngo MR D13C at the 145 
University Hospital of Tromsø and with a Phillips Achieva 3T scanner at the University 146 
Hospital of Oslo. At both sites, high resolution 3D T1-wheighted images were acquired. In 147 
Tromsø, we used a magnetization-prepared rapid gradient-echo (MPRAGE) sequence with 148 
the following parameters: Orientation = Sagittal; No. of slices = 176; Voxel size = 1 x 1 x 1; 149 
Slice thickness = 1 mm; repetition time (TR) = 2300ms; echo time (TE) = 2.98ms; field of 150 
view (FOV) = 256 x 256; Flip angle = 9º; and inversion time (TI) = 900ms. In Oslo, a 3D 151 




of slices = 184; Voxel size = 1 x 1 x 1; Slice thickness = 1 mm; TR = 2300ms; TE = 2.98ms; 153 
FOV = 256 x 256; Flip angle = 8º; and TI = 900ms. 154 
 155 
2.4. Image processing  156 
Surface reconstruction and volumetric segmentation was performed with FreeSurfer v6.0  157 
software (http://surfer.nmr.mgh.harvard.edu) version 6.0; Fischl et al. 2002, Fischl et al., 158 
2004) with the recon-all processing pipeline and the hippocampal subfields module (Iglesias 159 
et al., 2015). The pipeline includes motion correction, normalization to Talairach space, 160 
intensity bias correction, skull-stripping, surface registration and segmentation. Two of the 161 
authors (TRV and ADM) visually inspected image registration results. 162 
 163 
2.4.1 Selected brain volumes 164 
The following 12 HS are modeled by the FreeSurfer hippocampal subfields atlas (Iglesias et 165 
al., 2015) and were investigated in this study: The CA1, CA2/3, CA4, the molecular layer of 166 
the CA regions (ML), the Granule Cell layer of the Dentate Gyrus (GCDG), the pre-, 167 
parasubiculum, and the subiculum, the hippocampus-amygdala transition area (HATA), the 168 
fimbria, the hippocampal fissure and the hippocampal tail (Figure 1). We also investigated 169 
total GM and WM volumes, estimated total intracranial volume (eTIV) and whole brain 170 
volume (ventricles excluded). 171 
 172 
2.5. Mental health 173 
The Norwegian versions of the Beck's Depression Inventory (BDI-II) (Beck et al., 1988), and 174 
the State-Trait Anxiety Inventory (STAI) forms Y1 (state anxiety) and Y2 (trait anxiety) 175 
(Spielberger et al., 1970) was used to measure symptoms of depression and anxiety, 176 
respectively. The Eating Disorder Examination Questionnaire (EDE-Q) (Fairburn and Beglin, 177 
2008) was used to measure eating disorder symptoms. The EDE-Q consists of four subscales 178 
(restriction, concerns about eating, weight and figure) and a global scale. The Mini-179 
International Neuropsychiatric interview (M.I.N.I) 6.0 (Sheehan et al., 1998) was used to 180 
screen for comorbid mental health disorders before patients were assessed by a clinical 181 
specialist in psychology or medicine. IQ was measured by Wechslers Adult Intelligence Scale 182 
IV (WAIS-IV) or Wechslers Intelligence Scale for Children IV (WISC-IV) for participants 183 
<16 years of age (Wechsler, 2008, 2003).  184 
 185 




We performed tests of normality and inspected plots for all variables and found no violations 187 
of the assumptions for parametric tests. Group differences in demographic variables and 188 
psychometric measures were investigated by one-way analysis of variance. Linear regression 189 
analyses were used to investigate group differences on global GM and WM, adjusted for age, 190 
drug use and scanner site. Inspections of the cortical surface and subcortical volumes revealed 191 
a substantial spread of cortical volume reduction and volume reduction in several subcortical 192 
structures. To investigate whether brain volumes were affected by scanner site, we performed 193 
linear regression analyses using only HC participants with total GM and the whole 194 
hippocampus, adjusted for age and eTIV, as the outcome variables and scanner site as the 195 
independent variable. Scanner site, adjusted for age and eTIV, was not associated with total 196 
GM (b=0.02, p=0.44) or left hippocampus (b=-0.27, p=0.21), but was close to significant in 197 
the right hippocampus (b=-0.39, p=0.05). We adjusted for site in all further analyses. As an 198 
additional measure against the potential confounding effect of site, we re-performed the main 199 
analyses of hippocampus and HS in a subsample with participants from one scanner only 200 
(Supplement tables 1-2).  201 
A series of linear regression analyses was performed to investigate group differences 202 
in the whole hippocampus and HS volumes, averaged across hemispheres. All analyses were 203 
also performed separately for the two hemispheres. To adjust for potential confounding effect 204 
of age dispersion, depressive symptoms, individual differences in intracranial volume, 205 
psychopharmacological treatment and the two different scanners, the variables age, BDI-II 206 
score, eTIV, drug use and scanner site were entered as covariates. In a secondary series of 207 
analyses, we replaced eTIV with whole brain volume as a covariate to investigate whether 208 
volume reduction in the whole hippocampus and HS was affected by total brain volume. All 209 
analyses were also repeated with STAI-Y1 (measuring state anxiety symptoms) score 210 
replacing the depression score to adjust for potential confounding effect of anxiety symptoms. 211 
To further investigate the relationship between brain volumes and clinical measures in AN, 212 
we conducted group stratified linear regression analyses of all HS volumes that were 213 
significantly smaller in the AN group and the following variables: BMI, BMI-SDS, BMI-214 
increase, Weeks since admission (to inpatient care), Years since first GP consultation 215 
(regarding eating disorder symptoms), EDE-Q (four subscales and global scale) BDI-II, STAI 216 
Y1. In all models we added age, scanner site, drug use and eTIV as covariates to adjust for 217 
potential confounding effects. All results were corrected for errors of multiple comparisons 218 




01.ibm.com/support/docview.wss?uid=swg21476447) and a false discovery rate with q=0.05. 220 
All statistical analyses were performed using IBM SPSS 24. 221 
 222 
3. Results 223 
The AN group had significantly higher scores on self-report measures of mental illness and 224 
significantly lower BMI and BMI-SDS (Table 1). Linear regression analysis of global GM 225 
and WM volumes showed that AN patients had significantly reduced volume in cerebral GM 226 
and total brain volume. No group differences were found in cerebral WM and eTIV (Table 2). 227 
 All HS volumes except for the hippocampal fissure were significantly explained by 228 
group affiliation adjusted for site, age, depression score (BDI-II), drug use and eTIV, and 229 
remained significant after FDR correction (Tables 3-4). In the secondary analysis, where 230 
eTIV was replaced by brain volume as a covariate, the fimbria and the hippocampal tail where 231 
no longer significantly explained by group affiliations after correction for multiple 232 
comparisons (Table 4). When adjusting for anxiety, results were similar for the eTIV adjusted 233 
analyses, but none of the HS remained significant when adjusting for total brain volume 234 
(Supplement table 3). We conducted the same analyses on a subgroup collected from one 235 
single scanner (N=41) to avoid the potential confound of scanner variability and results 236 
showed similar results for the eTIV adjusted analyses, but none of the HS were significantly 237 
explained by group affiliation when adjusting for whole brain volume (Supplement table 1-2). 238 
Because we did not have a hypothesis about lateralization of volume reduction and because 239 
the results for the two hemispheres were highly similar, only results from analyses performed 240 
on volumes averaged across hemispheres are presented.  241 
In the group stratified regression analyses of HS of interest and clinical measures 242 
(BMI, BMI increase, duration of inpatient care, AN symptom duration, scores from EDE-Q, 243 
BDI-II and STAI measuring AN symptoms, depression and anxiety) results revealed 244 
significant relationships between BDI, STAI Y1 and several HS (Table 5). No significant 245 
associations were found regarding BMI and EDE-Q scores (Table 5), or any of the other AN-246 
related measures. We did not find any statistically significant associations between HS 247 
volumes and clinical measures in the HC group.  248 
 249 
4. Discussion 250 
The aim of the present study was to investigate hippocampal subfields in adolescents with 251 
restrictive AN compared to healthy age-matched controls. We found statistically significant 252 




depression score (BDI-II), scanner site and eTIV. Results showed that the AN group had 254 
smaller CA areas and less volume in the presubiculum, the molecular layers of the CA areas, 255 
the HATA and the GCDG. Most results remained significant also when adjusting for global 256 
brain volume which was expectedly reduced in the AN sample. This might indicate that the 257 
volume reduction in the hippocampus is more extensive than the general brain volume 258 
reduction, and that this structure is particularly vulnerable in AN. The fissure was not 259 
increased in the AN group as found in a previous study of adult AN patients (Burkert et al., 260 
2015). In their study of adult patients, Burkert et al. found volume reduction only in the 261 
fimbria and our results seem to indicate that hippocampus reduction is more extensive in 262 
adolescent AN patients and not specific to selected subfields. The reason for the discrepancy 263 
might be the young age of our sample and that the developing brain may respond differently 264 
to illness debut. Another explanation could be that GM areas normalize after the initial acute 265 
phase of AN. Our results are consistent with findings regarding global GM in AN. A recent 266 
meta-analyses of volumetric studies in AN found that adolescents had significantly greater 267 
GM volume loss compared to adults (Seitz et al., 2016).  268 
The use of different hippocampal segmentation methods complicates the comparison 269 
of the results of studies of HS. In their study of adult AN patients, Burkert and colleagues 270 
(Burkert et al., 2015) used FreeSurfer version 5.3, which performs a more crude segmentation 271 
and does not model all of the subfields. The previous version has been criticized for not 272 
agreeing well with volumes from histological studies (Schoene-Bake et al., 2014). The 273 
FreeSurfer v6.0 atlas is an improvement to previous atlases in that it is made from higher 274 
resolution images and is built from more cases, makes no assumptions about acquisition 275 
parameters and can model more subfields than any other atlas (Iglesias et al., 2015).  276 
Stress and excessive glucocorticoid exposure is often reported in severe mental health 277 
disorders and is proposed as the driving mechanism of hippocampal atrophy (Mondelli et al., 278 
2010; Sapolsky, 2000; Videbech and Ravnkilde, 2004; Watanabe et al., 2017). Higher self-279 
reported stress levels have been found to be associated with greater hippocampus reduction in 280 
major depressive patients (Treadway et al., 2015), and higher serum cortisol levels were 281 
found in first-episode depressive patients (Watanabe et al., 2017). Excessive hormone 282 
production can lead to volume reduction in the hippocampus, as seen in patients with the 283 
hypercorticolism disease Cushing’s syndrome (Starkman et al., 1992). Patients with AN often 284 
have comorbid depression and anxiety disorders (Kaye et al., 2004), report higher stress levels 285 
(Burkert et al., 2015) and have elevated cortisol levels (Mainz et al., 2012) and it is possible 286 




of depression was addressed by adjusting for BDI-II score in the main analyses of HS. The 288 
group effect was still present with this adjustment, indicating that depressive symptoms in our 289 
sample is not driving volume reduction in the hippocampus. Similar results were found when 290 
adding anxiety scores as a covariate, but none of the results from analyses with adjustments 291 
for whole brain volume remained significant after correction for multiple comparisons. These 292 
results may have been significant in a larger sample.  293 
 Group stratified analyses revealed significant, positive relationships between several 294 
HS and symptoms of depression and anxiety measured by BDI II and STAI Y1, and Y2, 295 
showing that patients with larger HS volumes had higher scores for these measures, indicating 296 
more severe symptoms. No such relationships were found in the HC group. These findings 297 
were somewhat unexpected since previous studies have found a reduction in hippocampus 298 
volume to be associated with depression and PTSD (Hayes et al., 2017; Treadway et al., 299 
2015). However, the relationship between depression and HS volume appear to be a matter of 300 
duration and not severity – i.e. more depressive episodes is associated with greater volume 301 
loss (Treadway et al., 2015). Depression in AN is found to be highly related to core symptoms 302 
of the disorder such as body dissatisfaction, and the assessment of comorbidity between these 303 
disorders is challenging (Espelage et al., 2003). Very few patients in our sample received a 304 
comorbid diagnosis according to the M.I.N.I interview, in spite of high scores on BDI and 305 
STAI. Furthermore, it is possible that patients that experienced less symptoms of depression 306 
and anxiety prior to admission will experience more emotional distress from being admitted to 307 
inpatient care. The patients in our study were recently admitted and scores on depression and 308 
anxiety scales may have been temporarily elevated due to the new imposed weight 309 
rehabilitation regimen. The relationship between symptoms of depression and anxiety and HS 310 
in our sample may thus be driven by related factors such as stress and coping mechanisms.    311 
The contribution of low BMI and emaciation to hippocampal volume loss in AN is 312 
unclear. Findings regarding global GM volume are inconsistent, but some studies have 313 
identified significant correlations with BMI (Seitz et al., 2015), lowest lifetime BMI and 314 
degree of weight loss prior to admission (Bomba et al., 2013). In addition, the fact that brain 315 
volume tends to normalize when body weight is restored (King et al., 2015; Mainz et al., 316 
2012) suggests that weight is a contributing factor in global cerebral volume reduction. One 317 
study found regional volume reductions in the ACC but not global GM (Mühlau et al., 2007) 318 
suggesting that some regions may be more vulnerable to malnourishment. In line with the 319 
previous study on HS (Burkert et al., 2015), we did not find a significant relationship between 320 




A limitation to our study is the use of two different scanners – a probable confounder 322 
of the results. To account for this, we re-performed the main analyses on a subgroup from 323 
only one scanner. These results were similar to the results from the main analyses, indicating 324 
that scanner site did not affect the main outcome in a large extent. However, the subgroup 325 
analyses had a low N (AN N=21) and this may not be sufficient to detect group differences. 326 
Although the most recent version of the FreeSurfer HS atlas used in this study is an 327 
improvement upon the previous version, there still are limitations regarding the boundaries 328 
between some of the subfields, for example the CA-fields. The CA4 and the dentate gyrus 329 
also overlap in the atlas, and it might not be possible to distinguish these two subfields 330 
practically. The atlas was built from manual delineations in elderly subjects and might not 331 
perform as well in younger populations (Iglesias et al., 2015). 332 
Further limitations of our study were that we did not have data available to control for 333 
variations in pretest severity of illness, notably periods of marked weight loss (i.e. a BMI < 334 
17) and lowest lifetime BMI or comorbidity prior to admission. The patients in our study had 335 
been admitted for a mean duration of 4.5 weeks with a large dispersion (SD=4.0 weeks) and 336 
were likely to have been on weight rehabilitation programs for several weeks. The mean BMI 337 
of 16.3 (SD=1.6) in the AN group suggests that not all of the patients were in the most acute 338 
phase of their illness. However, we did not find a significant association between BMI 339 
increase score, measured by subtracting the BMI at admission from the BMI at the day of the 340 
scan, and the HS, indicating that hippocampus volumes were not affected by patients’ weight 341 
gain during the first weeks of inpatient treatment.  342 
The present study is the first to investigate hippocampal subfields selectively in 343 
adolescent AN patients in an early stage of illness. The most important finding was that 344 
several HS were found to be significantly reduced in adolescent patients with AN compared 345 
to healthy controls. The effect was present when adjusting for depression and anxiety, 346 
suggesting that the extensive HS volume reduction in AN that is not driven by depression or 347 
anxiety. However, no AN characteristic variables were associated with the observed volume 348 
reduction. The positive association between depression and anxiety might be a result of 349 
associated factors such as stress and coping mechanisms. Future studies should include more 350 
elaborate measures of comorbidity and AN symptomatology, particularly measures of stress 351 
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N 21 20   
Age 15.2 (1.6) 15.7 (1.9) 1.5 .225 
BMI 16.1 (1.4) 21.8 (3.1) 60.4 <.001 
BMI-SDS -2.4 (1.3) 0.3 (1.0) 57.5 <.001 
Drugs (SSRI/GH)a 2/2 0   
Left hand dominant 1 3   
Weeks since admission 5.3 (7.0) -   
Years since first GP consult. 1.1 (1.2) -   
Note: One-way ANOVA. BMI = Body mass index. BMI-SDS = Standardized BMI values based on 
Norwegian norms for children. a 2 subjects on Serotonin reuptake inhibitor (SSRI), 2 on growth 
hormones (GH). Years since first GP consult. = Consultation concerning eating disorder symptoms.  
 
Supplement table 2 Hippocampal subfield volumes for adolescent AN and HC from 






Note: Statistics: Linear regression analyses with two different adjustments for brain size: eTIV 
(estimated total intracranial volume) and total brain volume without ventricles. In both sets of 
analyses covariates are group affiliation (group variable was coded AN = 0 and HC = 1), age, 
depression score (BDI-II), scanner site and drug use. Variables presented in bold are significant after 
FDR correction for multiple comparisons. CA = Cornu Ammonis. GCDG = Granule cell layer of the 




Adjusted for eTIV Adjusted for total brain volume 
Brain volume Beta p R-square Beta  p R-square 
Whole 
hippocampus 
-.424 .001 .558 -.211 .117 .586 
Tail -.399 .011 .304 -.321 .072 .283 
Subiculum -.216 .148 .323 -.004 .981 .360 
Presubiculum -.293 .063 .262 -.084 .615 .348 
Parasubiculum -.249 .125 .203 -.023 .891 .309 
Fissure -.069 .672 .182 -.001 .996 .101 
CA1 -.415 .001 .539 -.197 .142 .588 
CA2-3 -.373 .006 .493 -.254 .101 .455 
CA4 -.300 .031 .431 -.148 .352 .407 
ML -.439 .001 .549 -.229 .088 .590 
GCDG -.324 .018 .454 -.157 .311 .443 
HATA -.313 .019 .491 -.059 .666 .561 
Fimbria -.212 .206 .142 -.012 .946 .226 












Note: Table shows results from linear regression analyses with two different adjustments for brain 
size: eTIV (estimated total intracranial volume) and total brain volume without ventricles. In both sets 
of analyses covariates are group affiliation (group variable was coded AN = 0 and HC = 1), age, state 
anxiety (STAI-Y1), scanner site and drug use. Variables presented in bold are significant after FDR 
correction for multiple commparisons. CA = Cornu Ammonis. GCDG = Granule cell layer of the 




Adjusted for eTIV Adjusted for total brain volume 
 
 
Beta p R-square Beta  p R-square 
Whole 
hippocampus -.599 <.001 .431 -.371 .014 .538 
Tail -.413 .016 .303 -.249 .150 .371 
Subiculum -.437 .009 .349 -.266 .122 .378 
Presubiculum -.402 .015 .355 -.232 .164 .414 
Parasubiculum -.378 .026 .312 -.159 .341 .403 
Fissure -.035 .840 .232 -.032 .872 .154 
CA1 -.544 .001 .417 -.322 .037 .510 
CA2-3 -.523 .003 .316 -.386 .030 .357 
CA4 -.505 .004 .285 -.314 .070 .377 
ML -.627 <.001 .424 -.411 .008 .526 
GCDG -.547 .001 .349 -.343 .037 .444 
HATA -.538 .001 .413 -.319 .040 .506 
Fimbria -.298 .101 .192 -.157 .413 .209 











N 30 28   
Age 15.8 (1.7) 16.2 (1.9) 0.9  .343 
BMI 16.3 (1.6) 21.8 (3.1) 73.9  <.001 
BMI admission 15.2 (1.4) –   
BMI-increase 0.9 (0.6) –   
BMI-SDS -2.4 (1.2) 0.3 (1.1) 73.2 <.001 
Drugs (SSRI/GH)a 7 0   
Left hand dominant 2 2   
Weeks since admission* 4.5 (4.0) –   
Years since first GP 
consult.** 
1.6 (1.4) –   
     
FSIQ* 101.1 (12.0) 104.0 (8.2) 292.0 .068 
BDI II***  22.8 (11.8) 4.3 (5.1) 56.7  <.001 
STAI Y1*** 49.8 (14.1) 30.8 (9.7) 32.9  <.001 
STAI Y2*** 52.0 (15.2) 33.9 (10.9) 27.1  <.001 
EDE-Q restriction** 3.0 (2.0) 0.4 (0.5) 44.2 <.001 
EDE-Q eating** 2.3 (1.7) 0.2 (0.5) 37.1 <.001 
EDE-Q weight** 3.0 (1.8) 0.7 (0.8) 36.3 <.001 
EDE-Q figure** 3.9 (1.9) 0.9 (1.2) 50.1 <.001 
EDE-Q global** 3.0 (1.7) 0.6 (0.6) 53.7 <.001 
Mini sum* 1.0 (1.2) 0.1 (0.3) 17.8 <.001 
Note: Statistics: One-way ANOVA. BMI = Body mass index. BMI-SDS = Standardized BMI values based on 
Norwegian norms for children. a 5 subjects used Serotonin reuptake inhibitor (SSRI), 2 used growth hormones 
(GH). Years since first GP consult = Consultation concerning eating disorder symptoms. FSIQ = Full Scale 
Intelligence Quotient. BDI = Becks Depression Inventory II. STAI 1 & 2 = State Trait Anxiety questionnaire form 
Y1 (State anxiety) and Y2 (Trait anxiety). EDE-Q = Eating Disorder Examination Questionnaire. MINI sum = 
Sum of diagnoses from MINI except Anorexia nervosa.*AN N = 29. **AN N = 27. ***AN N = 25.    
 















Total gray matter 662812.9 (56607.4) 717920.5 (59586.9) -.426 <.001 .776 
Cerebral white matter 417027.1 (47223.0) 436765.0 (46027.6) -.100 .246 .681 
eTIV 1452452.6 (139298.6) 1485015.9 (121664.0) -.118 .360 .142 
Total brain volumea 1107935.4 (91540.3) 1184735.0 (94086.8) -.409 .001 .247 
Note: Statistics: Linear regression adjusting for age, drug use and site. eTIV = estimated total intracranial volume. 
Total gray and white matter was also adjusted for eTIV. Group variable was coded AN = 0 and HC = 1. Mean 
values are mm3. aVentricles were excluded from total brain volume.  
  









Whole hippocampus 3327.7 (299.8) 3566.7 (242.3) 6.7% 
HS:    
Tail 517.7 (55.8) 550.4 (54.3) 5.9% 
Subiculum 422.2 (39.4) 441.1 (34.8) 4.3% 
Presubiculum 307.4 (29.7) 326.7 (26.6) 5.9 % 
Parasubiculum 62.8 (8.1) 68.1 (6.3) 7.8 % 
Fissure 144.8 (18.6) 145.9 (18.6) 0.8 % 
CA1 610.3 (69.4) 661.7 (60.2) 7.8% 
CA2-3 187.2 (27.1) 206.0 (26.4) 9.1% 
CA4 241.0 (26.2) 258.0 (22.7) 6.6% 
Molecular layer 545.1 (51.3) 588.2 (43.7) 7.3% 
GCDG 280.7 (29.9) 301.4 (25.5) 6.9% 
HATA 61.2 (8.9) 67.1 (6.5) 8.8% 
Fimbria 92.0 (12.7) 98.1 (13.2) 6.2% 
Note: Values are mean mm3 and standard deviations, averaged across hemispheres. HS = 
Hippocampal subfields. CA = Cornu Ammonis. GCDG = Granule cell layer of the dentate 
gyrus. HATA = Hippocampus-amygdala transition area. % difference was calculated from 
mean volumes in mm3 (HC – AN). 
 
Table 4 Hippocampus volumes in adolescent AN vs. HC 
Note: Statistics: Linear regression analyses of group affiliation (AN vs. HC) and HS with two 
different adjustments for brain size: eTIV (estimated total intracranial volume) and total brain volume 
without ventricles. Group variable was coded AN = 0 and HC = 1. For both sets of analyses, 
covariates were age, depression score (BDI-II), scanner site and drug use. Variables presented in bold 
are significant after FDR correction for multiple comparisons. HS = Hippocampal subfields. CA = 
Cornu Ammonis. GCDG = Granule cell layer of the dentate gyrus. HATA = Hippocampus-amygdala 
transition area. 
  

















-.769 <.001 .525 -.542 .002 .588 
Tail -.483 .014 .359 -.306 .138 .400 
Subiculum -.651 .001 .442 -.511 .012 .444 
Presubiculum -.684 <.001 .461 -.526 .007 .495 
Parasubiculum -.645 .001 .422 -.432 .027 .482 
Fissure -.190 .353 .269 -.267 .263 .190 
CA1 -.649 <.001 .488 -.423 .021 .541 
CA2-3 -.611 .003 .345 -.470 .028 .371 
CA4 -.670 .001 .351 -.469 .024 .415 
ML -.776 <.001 .502 -.557 .002 .566 
GCDG -.687 .001 .402 -.475 .017 .469 
HATA -.667 <.001 .46 -.441 .018 .528 
Fimbria -.462 .031 .24 -.335 .148 .247 
Table 5: The association between hippocampal subfields and clinical measures in AN 
Note: Statistics: Linear regression adjusting for age. site. drug use and eTIV. Variables presented in 
bold are significant at the 5% level after FDR correction for multiple comparisons. BMI-SDS: 
Standardized body mass index (BMI) values based on Norwegian norms for children. BDI-II: Becks 
depression inventory II. EDE-Q: Eating disorder examination questionnaire (global score). STAI: State 
Trait Anxiety Inventory form Y1 (State anxiety) and Y2 (Trait anxiety). CA = Cornu Ammonis. GCDG 




BMI-SDS EDE-Q BDI-II STAI-Y1 
Brain volumes Beta p Beta p Beta p Beta p 
Total GM .136 .293 .180 .232 .242 .107 .066 .677 
         
Whole 
hippocampus -.270 .115 .124 .494 .565 <.001 .567 .001 
Tail .137 .489 .025 .906 .346 .084 .334 .105 
Subiculum -.321 .058 .152 .405 .612 <.001 .619 <.001 
Presubiculum -.177 .334 .109 .591 .595 .001 .446 .021 
Parasubiculum .169 .425 .235 .308 .617 .003 .487 .028 
CA1 -.204 .238 .178 .313 .473 .004 .522 .003 
CA2-3 -.222 .186 .017 .927 .264 .160 .338 .074 
CA4 -.352 .049 .047 .811 .477 .012 .488 .011 
ML -.291 .092 .140 .442 .557 .001 .582 .001 
GCDG -.341 .050 .055 .775 .486 .008 .496 .007 
HATA -.140 .436 .094 .629 .521 .004 .452 .016 
Fimbria -.080 .681 .121 .539 .438 .048 .284 .219 
